Bibliography
- Inanici F , YunusMB. History of fibromyalgia: past to present. Curr. Pain Headache Rep.8(5) , 369–378 (2004).
- Gran JT . The epidemiology of chronic generalized musculoskeletal pain. Best Pract. Res. Clin. Rheumatol.17 , 547–561 (2003).
- Lawrence RC , FelsonDT, HelmickCG et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 58 , 26–35 (2008).
- Wolfe F , RossK, AndersonJ et al. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38 , 19–28 (1995).
- White KP , SpeechleyM, HarthM, OstbyeT. The London fibromyalgia epidemiology study: the prevalence of fibromyalgia syndrome in London, Ontario. J. Rheumatol.26 , 1570–1576 (1999).
- Bradley LA . Pathophysiology of fibromyalgia. Am. J. Med.122 , S22–S30 (2009).
- Abeles AM , PillingerMH, SolitarBM, AbelesM. Narrative review: the pathophysiology of fibromyalgia. Ann. Intern. Med.146 , 726–734 (2007).
- Bennett RM , JonesJ, TurkDC, RussellIJ, MatallanaL. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet. Disord.8 , 27 (2007).
- Epstein SA , KayG, ClauwD et al. Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics 40 , 57–63 (1999).
- Cakit BD , TaskinS, NacirB, UnluI, GencH, ErdemHR. Comorbidity of fibromyalgia and cervical myofascial pain syndrome. Clin. Rheumatol.29 , 405–411 (2010).
- Schweinhardt P , SauroKM, BushnellMC. Fibromyalgia: a disorder of the brain? Neuroscientist14 , 415–421 (2008).
- Gracely RH , PetzkeF, WolfJM, ClauwDJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum.46 , 1333–1343 (2002).
- Desmeules JA , CedraschiC, RapitiE et al. Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum. 48 , 1420–1429 (2003).
- Kosek E , HanssonP. Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain70 , 41–51 (1997).
- Staud R , CannonRC, MauderliAP, RobinsonME, PriceDD, VierckCJ Jr. Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome. Pain102 , 87–95 (2003).
- Tanriverdi F , KaracaZ, UnluhizarciK, KelestimurF. The hypothalamo–pituitary–adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome. Stress10 , 13–25 (2007).
- Reynolds WJ , ChiuB, InmanRD. Plasma substance P levels in fibrositis. J. Rheumatol.15 , 1802–1803 (1988).
- Sarchielli P , ManciniML, FloridiA et al. Increased levels of neurotrophins are not specific for chronic migraine: evidence from primary fibromyalgia syndrome. J. Pain 8 , 737–745 (2007).
- Wolfe F , SmytheHA, YunusMB et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum. 33 , 160–172 (1990).
- Wolfe F , ClauwDJ, FitzcharlesMA et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. (Hoboken) 62(5) , 600–610 (2010).
- Wolfe F , ClauwDJ, FitzcharlesMA et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J. Rheumatol. 38 , 1113–1122 (2011).
- Kato K , SullivanPF, EvengårdB, PedersenNL. Chronic widespread pain and its comorbidities: a population-based study. Arch. Intern. Med.166 , 1649–1654 (2006).
- Goldenberg DL . Diagnosis and differential diagnosis of fibromyalgia. Am. J. Med.122(Suppl. 12) , S14–S21 (2009).
- Aaron LA , BuchwaldD. Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions. Best Pract. Res. Clin. Rheumatol.17 , 563–574 (2003).
- Häuser W , BernardyK, ArnoldB, OffenbacherM, SchiltenwolfM. Efficacy of multicomponent treatment in fibromyalgia syndrome: a meta-analysis of randomized controlled clinical trials. Arthritis Rheum.61 , 216–224 (2009).
- Moore RA , DerryS, WiffenPJ, McQuayHJ. Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst. Rev. doi: 10.1002/14651858.CD008242. (2010) (Epub ahead of print).
- Arnold LM , KeckPE Jr, Welge JA. Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics41 , 104–113 (2000).
- Tofferi JK , JacksonJL, O‘MalleyPG. Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum.51 , 9–13 (2004).
- Norregaard J , VolkmannH, Danneskiold-SamsoB. A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain61 , 445–449 (1995).
- Anderberg UM , MarteinsdottirI, Von Knorring L. Citalopram in patients with fibromyalgia – a randomized, double-blind, placebo-controlled study. Eur. J. Pain4 , 27–35 (2000).
- Wolfe F , CatheyMA, HawleyDJ. A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand. J. Rheumatol.23 , 255–259 (1994).
- Goldenberg D , MayskiyM, MosseyC et al. A randomized, double-blind cross-over trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum. 39 , 1852–1859 (1996).
- Arnold LM , HessEV, HudsonJI et al. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am. J. Med. 112 , 191–197 (2002).
- Patkar AA , MasandPS, KrulewiczS et al. A randomized, controlled trial of controlled release paroxetine in fibromyalgia. Am. J. Med. 120 , 448–454 (2007).
- Arnold LM . The pathophysiology, diagnosis and treatment of fibromyalgia. Psyciatr. Clin. North Am.33(2) , 375–408 (2010).
- Suzuki R , RyghLJ, DickensonAH. Bad news from the brain: descending 5-HT pathways that control spinal pain processing. Trends Pharmacol. Sci.2512 , 613–617 (2004).
- Lunn MPT , HughesRAC, WiffenPJ. Duloxetine for treating painful neuropathy or chronic pain. Cochrane Database Syst. Rev.4 , CD007115 (2009).
- Clauw DJ , MeaseP, PalmerRH et al. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple dose clinical trial. Clin. Ther. 30 , 1988–1200 (2008).
- Mease PJ , ClauwDJ, GendreauM et al. The efficacy and safety of milnacipran for treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial. J. Rheumatol. 36 , 398–409 (2009).
- Harvey AT , RudolphRL, PreskornSH. Evidence of the dual mechanisms of action of venlafaxine. Arch. Gen. Psychiatry57 , 503–509 (2000).
- Dwight MM , ArnoldLM, O‘BrienH, et al. An open clinical trial of venlafaxine treatment of fibromyalgia. Psychosomatics39 , 14–17 (1998).
- Zijlstra TR , BarendregtPJ, van de Laar MAF. Venlafaxine in fibromyalgia: results of a randomized, placebo-controlled, double blind trial. Arthritis Rheum.46 , S105 (2002).
- Moore RA , StraubeS, WiffenPJ, DerryS, McQuayHJ. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst. Rev.3 , CD007076 (2009).
- Arnold LM , GoldenbergDL, StanfordSB, et al. Gabapentin in the treatment of fibromyalgia. A randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum.56 , 1336–1344 (2007).
- Rossy LA , BuckelewSP, DorrN et al. A meta-analysis of fibromyalgia treatment interventions. Ann. Behav. Med. 21 , 180–191 (1999).
- Goldenberg DL , FelsonDT, DinermanH. A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum.29 , 1371–1377 (1986).
- Fossaluzza V , De Vita S. Combined therapy with cyclobenzaprine and ibuprofen in primary fibromyalgia syndrome. Int. J. Clin. Pharmacol. Res.12 , 99–102 (1992).
- Clark S , TindallE, BennettRM. A double blind crossover trial of prednisone versus placebo in the treatment of fibrositis. J. Rheumatol.12 , 980–983 (1985).
- Harris RE , ClauwDJ, ScottDJ, McLeanSA, GracelyRH, ZubietaJK. Decreased central mu-opiod receptor availability in fibromyalgia. J. Neurosci.27(37) , 10000–10006 (2007).
- Chu LF , ClarkDJ, AngstMS. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J. Pain7 , 43–48 (2006).
- Ngian GS , GuymerEK, LittlejohnGO. The use of opioids in fibromyalgia. Int J. Rheum. Dis.14(1) , 6–11 (2011).
- Biasi G , MancaS, ManganelliS, MarcolongoR. Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. Int. J. Clin. Pharmacol. Res.18(1) , 13–19 (1998).
- Bennett RM , KaminM, KarimR et al. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am. J. Med. 114 , 537–545 (2003).
- Busch AJ , BarberKA, OverendTJ, PelosoPMJ, SchachterCL. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst. Rev.4 , CD003786 (2007).
- Langhorst J , KloseP, MusialF et al. Efficacy of acupuncture in fibromyalgia syndrome – a systematic review with a meta-analysis of controlled clinical trials. Rheumatology 49 , 778–788 (2010).
- Nielson WR , JensenMP. Relationship between changes in coping and treatment outcome in patients with fibromyalgia syndrome. Pain109 , 233–241 (2004).
- Bernardy K , FüberN, KöllnerV, HäuserW. Efficacy of cognitive-behavioral therapies in fibromyalgia syndrome–a systematic review and meta-analysis of randomized controlled trials. J. Rheumatol.37(10) , 1991–2005 (2010).
- Glombiewski JA , SawyerAT, GutermannJ, KoenigK, RiefW, HofmannSG. Psychological treatments for fibromyalgia: a meta-analysis. Pain151 , 280–295 (2010).
- Holdcraft LC , AssefiN, BuchwaldD. Complementary and alternative medicine in fibromyalgia and related syndromes. Best Pract. Res. Clin. Rheumatol.17 , 667–683 (2003).
- De Silva V , El-MetwallyA, ErnstE. Evidence for the efficacy of complementary and alternative medicines in the management of fibromyalgia: a systematic review. Rheumatology49(6) , 1063–1068 (2010).